Halmos B, Burke T, Kalyvas C, Vandormael K, et al. Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison. Lung Cancer 2021;155:175-182.
PMID: 33839603